Arcturus Therapeutics Ltd
(ARCT)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 03-2013 | 12-2012 | 09-2012 | 06-2012 | 12-2011 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -377 | -1,570 | -1,284 | -1,001 | -3,920 |
| Depreciation Amortization | 1 | 7 | 6 | 4 | 6 |
| Accounts receivable | -45 | N/A | 63 | 56 | N/A |
| Accounts payable and accrued liabilities | -2 | N/A | -117 | -102 | N/A |
| Other Working Capital | 189 | -30 | -60 | -5 | 9 |
| Other Operating Activity | 53 | 13 | 76 | 62 | 1,545 |
| Operating Cash Flow | $-181 | $-1,580 | $-1,316 | $-986 | $-2,360 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | N/A | N/A | 517 | 465 | N/A |
| PPE Investments | N/A | 0 | N/A | N/A | -20 |
| Purchase Of Investment | N/A | N/A | 2 | 2 | N/A |
| Sale Of Investment | N/A | N/A | 507 | 507 | N/A |
| Other Investing Activity | 0 | 1,020 | 0 | 0 | -1,020 |
| Investing Cash Flow | $N/A | $1,020 | $1,026 | $974 | $-1,040 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | 115 | N/A | 267 | N/A | N/A |
| Other Financing Activity | 0 | 600 | 0 | 0 | 2,620 |
| Financing Cash Flow | $115 | $600 | $267 | $N/A | $2,620 |
| Beginning Cash Position | 97 | 50 | 55 | 55 | 830 |
| End Cash Position | 31 | 90 | 32 | 43 | 50 |
| Net Cash Flow | $-66 | $40 | $-23 | $-12 | $-780 |
| Free Cash Flow | |||||
| Operating Cash Flow | -181 | -1,580 | -1,316 | -986 | -2,360 |
| Free Cash Flow | -181 | -1,580 | -1,316 | -986 | -2,360 |